Literature DB >> 8008424

New findings and symptomatic treatment for neurolathyrism, a motor neuron disease occurring in north west Bangladesh.

A Haque1, M Hossain, J K Khan, Y H Kuo, F Lambein, J De Reuck.   

Abstract

Neurolathyrism is a form of spastic paraparesis caused by the neuroexcitatory amino acid 3-N-oxalyl-L-2,3-diaminopropanoic acid (beta-ODAP) present in the seeds and foliage of Lathyrus sativus. The disease is irreversible and usually nonprogressive. Tolperisone HCl, a centrally acting muscle relaxant, has been shown to reduce significantly the spasticity in neurolathyrism patients. Sporadic occurrence of HTLV-1 infection (0.9%) and of osteolathyrism was found among the neurolathyrism patients. Osteolathyrism is linked to the consumption of the green shoots of Lathyrus sativus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008424     DOI: 10.1038/sc.1994.35

Source DB:  PubMed          Journal:  Paraplegia        ISSN: 0031-1758


  4 in total

1.  Neurotoxic potential of three structural analogs of beta-N-oxalyl-alpha,beta-diaminopropanoic acid (beta-ODAP).

Authors:  I A Omelchenko; R K Jain; M A Junaid; S L Rao; C N Allen
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

2.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

3.  Neurolathyrism With Deep Vein Thrombosis and Bony Exostosis: Are They New Forms of Angiolathyrism and Osteolathyrism?

Authors:  Pradeep Kumar; Arun Prasad; Giridhar M F
Journal:  Cureus       Date:  2022-08-05

4.  Research on motor neuron diseases konzo and neurolathyrism: trends from 1990 to 2010.

Authors:  Delphin Diasolua Ngudi; Yu-Haey Kuo; Marc Van Montagu; Fernand Lambein
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.